488 related articles for article (PubMed ID: 33071950)
1. The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease.
Hanslik KL; Ulland TK
Front Neurol; 2020; 11():570711. PubMed ID: 33071950
[TBL] [Abstract][Full Text] [Related]
2. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
[TBL] [Abstract][Full Text] [Related]
3. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
4. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
Yang J; Wise L; Fukuchi KI
Front Immunol; 2020; 11():724. PubMed ID: 32391019
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer's disease.
Yang Z; Liu J; Wei S; Deng J; Feng X; Liu S; Liu M
Front Pharmacol; 2022; 13():1077222. PubMed ID: 36699095
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome activation drives tau pathology.
Ising C; Venegas C; Zhang S; Scheiblich H; Schmidt SV; Vieira-Saecker A; Schwartz S; Albasset S; McManus RM; Tejera D; Griep A; Santarelli F; Brosseron F; Opitz S; Stunden J; Merten M; Kayed R; Golenbock DT; Blum D; Latz E; Buée L; Heneka MT
Nature; 2019 Nov; 575(7784):669-673. PubMed ID: 31748742
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.
Van Zeller M; Dias D; Sebastião AM; Valente CA
J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341
[TBL] [Abstract][Full Text] [Related]
9. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.
Barczuk J; Siwecka N; Lusa W; Rozpędek-Kamińska W; Kucharska E; Majsterek I
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012243
[TBL] [Abstract][Full Text] [Related]
10. Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
Zhang L; Gai Y; Liu Y; Meng D; Zeng Y; Luo Y; Zhang H; Wang Z; Yang M; Li Y; Liu Y; Lai Y; Yang J; Wu G; Chen Y; Zhu J; Liu S; Yu T; Zeng J; Wang J; Zhu D; Wang X; Lan X; Liu R
Clin Transl Med; 2024 Mar; 14(3):e1623. PubMed ID: 38488468
[TBL] [Abstract][Full Text] [Related]
11. Glycogen Synthase Kinase-3β, NLRP3 Inflammasome, and Alzheimer's Disease.
Jia YR; Guo ZQ; Guo Q; Wang XC
Curr Med Sci; 2023 Oct; 43(5):847-854. PubMed ID: 37721665
[TBL] [Abstract][Full Text] [Related]
12. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease.
Vontell RT; de Rivero Vaccari JP; Sun X; Gultekin SH; Bramlett HM; Dietrich WD; Keane RW
Brain Pathol; 2023 Jul; 33(4):e13142. PubMed ID: 36579934
[TBL] [Abstract][Full Text] [Related]
13. The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets.
Liang T; Zhang Y; Wu S; Chen Q; Wang L
Front Pharmacol; 2022; 13():845185. PubMed ID: 35250595
[TBL] [Abstract][Full Text] [Related]
14. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional microglia and tau pathology in Alzheimer's disease.
Ayyubova G
Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
[TBL] [Abstract][Full Text] [Related]
16. [Nucleotide-binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 Inflammasome in Alzheimer's Disease].
Feng YY; Chen H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):788-795. PubMed ID: 34728041
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease.
Jha D; Bakker ENTP; Kumar R
J Neurochem; 2023 Feb; ():. PubMed ID: 36802053
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in Alzheimer's Disease: Focus on NLRP1 and NLRP3 Inflammasomes.
de Brito Toscano EC; Rocha NP; Lopes BNA; Suemoto CK; Teixeira AL
Curr Protein Pept Sci; 2021; 22(8):584-598. PubMed ID: 34530705
[TBL] [Abstract][Full Text] [Related]
19. The NLRP3 inflammasome is involved in the neuroprotective mechanism of neural stem cells against microglia-mediated toxicity in SH-SY5Y cells via the attenuation of tau hyperphosphorylation and amyloidogenesis.
Chan EWL; Krishnansamy S; Wong C; Gan SY
Neurotoxicology; 2019 Jan; 70():91-98. PubMed ID: 30408495
[TBL] [Abstract][Full Text] [Related]
20. Miltefosine as a PPM1A activator improves AD-like pathology in mice by alleviating tauopathy via microglia/neurons crosstalk.
Lv J; Shen X; Shen X; Li X; Jin Z; Ouyang X; Lu J; Zhu D; Wang J; Shen X
Brain Behav Immun Health; 2022 Dec; 26():100546. PubMed ID: 36388134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
